NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma
Authors:
- Eva AlvarezEAEva Alvarez
- Elisabet CantóECElisabet Cantó
- Silvia VidalSilvia Vidal
- José Luis Rodríguez-SánchezJRJosé Luis Rodríguez-Sánchez
- Jorge SierraJSJorge Sierra
- Javier BrionesJBJavier Briones
- 1 January 2008
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 36 (1) , 69-77
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III (C03/010, G03/179)
This publication has 47 references indexed in Scilit:
- FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphomaBlood, 2006
- Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodiesCancer and Metastasis Reviews, 2005
- Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s LymphomaClinical Cancer Research, 2004
- Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular LymphomaJournal of Clinical Oncology, 2003
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Mechanism of Cytotoxicity Induced by Chimeric Mouse Human Monoclonal Antibody IDEC-C2B8 in CD20-Expressing Lymphoma Cell LinesCellular Immunology, 2000
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Studies Evaluating the Antitumor Activity and Toxicity of Interleukin-15, a New T Cell Growth Factor: Comparison with Interleukin-2Cellular Immunology, 1995